These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28394351)

  • 1. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.
    Ansari MA; Pedergnana V; L C Ip C; Magri A; Von Delft A; Bonsall D; Chaturvedi N; Bartha I; Smith D; Nicholson G; McVean G; Trebes A; Piazza P; Fellay J; Cooke G; Foster GR; ; Hudson E; McLauchlan J; Simmonds P; Bowden R; Klenerman P; Barnes E; Spencer CCA
    Nat Genet; 2017 May; 49(5):666-673. PubMed ID: 28394351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
    Fitzmaurice K; Hurst J; Dring M; Rauch A; McLaren PJ; Günthard HF; Gardiner C; Klenerman P; ;
    Gut; 2015 May; 64(5):813-9. PubMed ID: 24996883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.
    Lange CM; Roomp K; Dragan A; Nattermann J; Michalk M; Spengler U; Weich V; Lengauer T; Zeuzem S; Berg T; Sarrazin C
    J Hepatol; 2010 Dec; 53(6):1022-8. PubMed ID: 20800922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.
    Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC
    PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.
    Gaudieri S; Rauch A; Pfafferott K; Barnes E; Cheng W; McCaughan G; Shackel N; Jeffrey GP; Mollison L; Baker R; Furrer H; Günthard HF; Freitas E; Humphreys I; Klenerman P; Mallal S; James I; Roberts S; Nolan D; Lucas M
    Hepatology; 2009 Apr; 49(4):1069-82. PubMed ID: 19263475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
    Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.
    Hydes TJ; Moesker B; Traherne JA; Ashraf S; Alexander GJ; Dimitrov BD; Woelk CH; Trowsdale J; Khakoo SI
    Tissue Antigens; 2015 Oct; 86(4):267-75. PubMed ID: 26381047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.
    Ydreborg M; Westin J; Rembeck K; Lindh M; Norrgren H; Holmberg A; Wejstål R; Norkrans G; Cardell K; Weiland O; Lagging M
    PLoS One; 2013; 8(11):e80172. PubMed ID: 24244641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
    Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
    Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes.
    Chaturvedi N; Svarovskaia ES; Mo H; Osinusi AO; Brainard DM; Subramanian GM; McHutchison JG; Zeuzem S; Fellay J
    Elife; 2019 Sep; 8():. PubMed ID: 31478832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
    Ansari MA; Aranday-Cortes E; Ip CL; da Silva Filipe A; Lau SH; Bamford C; Bonsall D; Trebes A; Piazza P; Sreenu V; Cowton VM; ; Hudson E; Bowden R; Patel AH; Foster GR; Irving WL; Agarwal K; Thomson EC; Simmonds P; Klenerman P; Holmes C; Barnes E; Spencer CC; McLauchlan J; Pedergnana V
    Elife; 2019 Sep; 8():. PubMed ID: 31478835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.
    Maekawa S; Sakamoto M; Miura M; Kadokura M; Sueki R; Komase K; Shindo H; Komatsu N; Shindo K; Kanayama A; Ohmori T; Amemiya F; Takano S; Yamaguchi T; Nakayama Y; Kitamura T; Inoue T; Okada S; Enomoto N
    Hepatology; 2012 Nov; 56(5):1611-21. PubMed ID: 22577043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immunity shape circulating HCV strains.
    Gaudieri S; Lucas M
    Nat Genet; 2017 Apr; 49(5):657-658. PubMed ID: 28442794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
    Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
    J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.
    Hayashi K; Katano Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
    Liver Int; 2011 Oct; 31(9):1359-65. PubMed ID: 21745312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
    Kuniholm MH; Gao X; Xue X; Kovacs A; Marti D; Thio CL; Peters MG; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Young MA; Strickler HD; Carrington M
    J Infect Dis; 2011 Jun; 203(12):1807-14. PubMed ID: 21606539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.